A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma
Clinical trial NCT00523640 · TERMINATED
Trial details
- NCT number
- NCT00523640
- Sponsor
- University of Chicago
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2011-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.